Augmedix (AUGX)
(Real Time Quote from BATS)
$0.75 USD
-0.02 (-2.69%)
Updated Jun 18, 2024 10:46 AM ET
2-Buy of 5 2
C Value D Growth D Momentum D VGM
Price, Consensus and EPS Surprise
AUGX 0.75 -0.02(-2.69%)
Will AUGX be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for AUGX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for AUGX
Health Catalyst (HCAT) Q1 Earnings Beat Estimates
How Much Upside is Left in Augmedix, Inc. (AUGX)? Wall Street Analysts Think 36.67%
AUGX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Augmedix, Inc. (AUGX) is on the Move, Here's Why the Trend Could be Sustainable
Privia Health (PRVA) Q3 Earnings Miss Estimates
Definitive Healthcare Corp. (DH) Soars 7.1%: Is Further Upside Left in the Stock?
Other News for AUGX
Augmedix Maintains Financial Outlook and Hosts Investor Chat
Analysts Conflicted on These Healthcare Names: Inotiv (NOTV), BioNTech SE (BNTX) and Augmedix (AUGX)
Augmedix Reiterates Second Quarter and Full Year 2024 Outlook
Augmedix reiterates FY24 revenue $52M-$55M, consensus $53.21M
Predictive Oncology, Augmedix, Cue Health among healthcare movers